Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">ARFI grade</td><td class="align_center">ARFI values (m/sec)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Normal</td><td class="align_center">1.0–1.5</td></tr><tr><td class="align_left">Mild fibrosis</td><td class="align_center">1.5–1.75</td></tr><tr><td class="align_left">Moderate fibrosis</td><td class="align_center">1.75–2.1</td></tr><tr><td class="align_left">Severe fibrosis</td><td class="align_center">&gt;2.1</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>ARFI (acoustic radiation force impulse) values for liver stiffness by SWE.</div>

Case Reports in Medicine

tab1

Table 1

Table 1: Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience 

Table 1 | Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience 